Drug comparisons
Vildagliptin vs Dulaglutide
Vildagliptin is an oral DPP-4 inhibitor that prolongs incretin hormones to stimulate glucose-dependent insulin secretion, while Dulaglutide is an injectable GLP-1 receptor agonist that mimics GLP-1 to regulate blood sugar. Compare their mechanisms, side effects, and suitability for type 2 diabetes.
No comparison dimensions are available for this page.
Clinical context
Patients with type 2 diabetes seeking to compare oral DPP-4 inhibitors like Vildagliptin with injectable GLP-1 agonists like Dulaglutide.
Bottom line
The better option between Vildagliptin and Dulaglutide depends on the patient's preference for oral versus injectable medication and their specific health needs.
All medication comparisons